NKTX 2.37 (+7.73%)
US65487U1088BiotechnologyBiotechnology

Nkarta (NKTX) Stock Highlights

2.37 | +7.73%
2024-12-21 06:14:48
Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer. The company is focused on leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. It is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body for the treatment of cancer. The companys operations are based in South San Francisco, California and it operates in one segment.

Statistics

Range Today
2.15 2.4
Volume Today 1.92M
Range 1 Year
2.08 16.24
Volume 1 Year 316.09M
Range 3 Year
1.28 20.35
Volume 3 Year 851.88M
Range 10 Year
1.28 79.16
Volume 10 Year 949.21M

Highlights

Market Capitalization 225.11M (small)
Floating Shares 40.59M
Current Price 2.37
Price To Earnings -1.71
Price To Book 0.52
Earnings Per Share -1.92
Payout Ratio 0%

Performance

Latest +7.73%
1 Month -4.82%
3 Months -55.53%
6 Months -54.68%
1 Year -38.44%
3 Years -83.86%
5 Years -95.65%
10 Years -95.65%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.